Astellas, Sony partner up for antibody-drug conjugate platform to create 'better performing' drugs
Astellas and Sony Corporation have teamed up to develop a new antibody-drug conjugate platform that delivers drugs to the target cells in a bid to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
